Gilead price target raised to $128 from $125 at Oppenheimer

Oppenheimer analyst Matthew Biegler raised the firm’s price target on Gilead (GILD) to $128 from $125 and keeps an Outperform rating on the shares. The firm notes Gilead posted a solid Q2 with 4% revenue growth. Most observers remain fixated on YEZTUGO’s launch, but in Oppenheimer’s view that misses the bigger picture, that the company is humming along across its three business units.